Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Resistant Hypertension in Patients With Type-II-Diabetes Mellitus (RESIST)

This study has been completed.
Information provided by (Responsible Party):
Trine Koustrup Soender, Svendborg Hospital Identifier:
First received: January 25, 2010
Last updated: October 9, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)